NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
No Result
View All Result
Home ALL Healthcare

RedHill Biopharma’s Talicia® added to Medi-Cal Contract Drug List with No Prior Authorization Requirements

by Ed Johnson
October 7, 2021
A A

Addition of Talicia by Medi-Cal Fee-For-Service (FFS) Contract Drug List (CDL) with no prior authorization is an important expansion of coverage for California patients and continues to increase Talicia’s overall unrestricted coverage®

Coverage commenced for two million patients in Medi-Cal’s FFS plan on October 1st, 2021
Talicia is the first and only FDA-approved rifabutin-based therapy for H. pylori infection, designed as a first-line option to address the high resistance of H. pylori bacteria to standard-of-care therapies

H. pylori bacterial infection is a Group 1 carcinogen and the strongest risk factor for gastric cancer; H. pylori affects approximately 35% of the U.S. population®

TEL-AVIV, Israel and RALEIGH, N.C., Oct. 6, 2021 — RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that Medi-Cal – California’s Medicaid Health Care program covering two million patients – has added Talicia (omeprazole magnesium, amoxicillin and rifabutin)®1 to its Contract Drug List (CDL) for H. pylori treatment, with no prior authorization required, effective October 1, 2021.

Coverage for Talicia commenced for two million patients in Medi-Cal’s California FFS plan on October 1, 2021.

“Medi-Cal’s addition of Talicia with no prior authorization required is an important step in Talicia’s continuing growth and we are pleased that it will be made available to Medi-Cal’s 2 million FFS lives,” said Rick Scruggs, RedHill’s Chief Commercial Officer. “There is growing recognition of the need to employ effective, first-line therapy against H. pylori infections that does not rely on clarithromycin and that patients can tolerate well and adhere to over 14 days of therapy. Talicia meets those criteria.”  

Tags: < Partnership
ShareTweetShareSend

Related Industries

Healthcare

Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.

September 20, 2023
Healthcare

BD Ranks in Top 10 for Transparency, Awarded Best Code of Conduct in 2023 U.S. Transparency Awards

September 20, 2023
Healthcare

Celanese Announces Agreement with the Population Council for Sustained Release Dual-API Therapeutic

September 13, 2023
Healthcare

Thermo Fisher Scientific and National Minority Quality Forum Collaborate to Make Clinical Research More Accessible to Historically Underserved Communities

September 8, 2023
Healthcare

Abbott to Acquire Bigfoot Biomedical, Furthering Efforts to Develop Personalized, Connected Solutions for People with Diabetes

September 6, 2023
Healthcare

AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION

September 2, 2023

Accelera by Cummins, Daimler Truck and PACCAR form a joint venture to advance battery cell production in the United States

September 8, 2023

...

BMW, Ford and Honda Agree to Create ChargeScape, a New Company Focused on Optimizing Electric Vehicle Grid Services

September 13, 2023

...

SABIC AN in collaborative venture with US companies to support Sustainable Agriculture

September 4, 2023

...

FairPrice Group and ExxonMobil join forces to raise more than S$100,000 for Children’s Aid Society in annual charity car wash

September 24, 2023

...

AIG Appoints Patricia J. Walsh as Executive Vice President and General Counsel

September 29, 2023

...

In confidential computing, data remains encrypted for as long as possible and until it is inside a secure enclave where it can be decrypted for processing. Encrypted computing takes confidential computing to a new level by using a technique called fully homomorphic encryption, which allows the hardware to process the data without it ever being decrypted. In essence, the processor performs calculations directly on the encrypted data. (Credit: Intel Corporation)

Intel Innovation 2023: Accelerating the Convergence of AI and Security

September 21, 2023

...

DuPont Names Recipients of 2023 Lavoisier Medal and Pedersen Award

September 8, 2023

...

Harrington Process Solutions, a Leading Specialty Distributor of Flow Control Process Solutions, to be Acquired by Bain Capital Private Equity

September 8, 2023

...

Soil Health Institute and Cargill Partner to Advance Water Stewardship Through Improved Soil Health

September 15, 2023

...

NORTH AMERICAN BUSINESS (www.na-biz.com) is a leading source of business and corporate news, information, industry trends, market updates and insights across a broad spectrum of industries in North America and worldwide.

MENU

  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

CONTACT US

EDITORIAL:     editor#na-biz.com

PARTNERSHIP:     biz#na-biz.com

HUMAN RESOURCE:     hr#na-biz.com

* (replace # with @)

  • Official Site

Copyright © NORTH AMERICAN BUSINESS All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © NORTH AMERICAN BUSINESS All rights reserved.